BIOMAT Database Logo BIOMAT Database Logo

Changes in trough levels of whole blood cyclosporine and graft function of a kidney transplant recipient with onset of hypothyroidism after transplantation. 1996

M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
Department of Internal Medicine, Sakura National Hospital, Chiba, Japan.

The immunosuppressive and toxic effects of cyclosporine (CsA) are affected by many factors. We present the first case of a kidney transplant patient who had an onset of hypothyroidism about two months after the transplantation. In this case, trough levels of whole blood CsA and total serum cholesterol levels increased at the same time. But the decrease in renal function was not as severe as expected from the very high trough levels of whole blood CsA. Elevation of the trough level of whole blood CsA may be due to a decrease in CsA clearance resulting from the decreased cytochrome P-450 activity in hypothyroidism. Furthermore, a decrease in thyroid hormone level and increase in plasma lipoprotein level might have affected the distribution of CsA, and this change might have influenced the toxic effect of CsA In conclusion, our case suggests that thyroid function and plasma lipoprotein level should be considered important factors that affect the pharmacokinetics and action of CsA.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D008297 Male Males
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
Mycophenolic acid trough levels after kidney transplantation in a cyclosporine-free protocol.
January 2000, Transplant international : official journal of the European Society for Organ Transplantation,
M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
[Measuring cyclosporine levels in whole blood in kidney transplantation].
January 1998, Revista da Associacao Medica Brasileira (1992),
M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
[Elevated cyclosporine A trough levels in HCV positive kidney transplant recipients].
January 2003, Revista da Associacao Medica Brasileira (1992),
M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
Increased cyclosporine blood levels after nisoldipine administration in a renal transplant recipient.
November 2002, Transplant international : official journal of the European Society for Organ Transplantation,
M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
Cyclosporine trough levels and its side effects in kidney transplant recipients.
April 2010, Iranian journal of kidney diseases,
M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
Cyclosporine trough levels in renal graft recipients.
November 1999, Journal of the Indian Medical Association,
M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients.
November 1999, Transplantation,
M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
Elevated blood concentrations of cyclosporine and kidney failure after bezafibrate in renal graft recipient.
January 1996, The Annals of pharmacotherapy,
M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient.
June 1996, Clinical neuropharmacology,
M Nishimura, and K Yamada, and K Matsushita, and K Sakamoto, and T Saisu, and H Kashiwabara, and T Yokoyama
Acute phosphate nephropathy in a kidney transplant recipient with delayed graft function.
February 2009, Transplantation,
Copied contents to your clipboard!